NPPB and hydrops fetalis: NT‐proBNP is currently still the most studied and reliable blood marker for HF diagnosis, but clinicians need to consider the impact of patient factors when interpreting test results and deciding, with the patient, on the most appropriate next step in the clinical pathway.